BR112013031564A2 - de-glicosilação in vivo de proteínas recombinantes por co- expressão com pngase f. - Google Patents

de-glicosilação in vivo de proteínas recombinantes por co- expressão com pngase f.

Info

Publication number
BR112013031564A2
BR112013031564A2 BR112013031564A BR112013031564A BR112013031564A2 BR 112013031564 A2 BR112013031564 A2 BR 112013031564A2 BR 112013031564 A BR112013031564 A BR 112013031564A BR 112013031564 A BR112013031564 A BR 112013031564A BR 112013031564 A2 BR112013031564 A2 BR 112013031564A2
Authority
BR
Brazil
Prior art keywords
pngase
glycosylation
vivo
expression
recombinant proteins
Prior art date
Application number
BR112013031564A
Other languages
English (en)
Other versions
BR112013031564B1 (pt
Inventor
Mammedov Tarlan
Yusibov Vidadi
Original Assignee
Ibio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ibio Inc filed Critical Ibio Inc
Publication of BR112013031564A2 publication Critical patent/BR112013031564A2/pt
Publication of BR112013031564B1 publication Critical patent/BR112013031564B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
BR112013031564-4A 2011-06-07 2012-06-07 Métodos para geração e expressão de um polipeptídio e sistema de expressão BR112013031564B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161494141P 2011-06-07 2011-06-07
US61/494,141 2011-06-07
US201161564427P 2011-11-29 2011-11-29
US61/564,427 2011-11-29
PCT/US2012/041340 WO2012170678A1 (en) 2011-06-07 2012-06-07 In vivo de-glycosylation of recombinant proteins by co-expression with pngase f

Publications (2)

Publication Number Publication Date
BR112013031564A2 true BR112013031564A2 (pt) 2017-06-27
BR112013031564B1 BR112013031564B1 (pt) 2021-11-03

Family

ID=46397622

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013031564-4A BR112013031564B1 (pt) 2011-06-07 2012-06-07 Métodos para geração e expressão de um polipeptídio e sistema de expressão

Country Status (6)

Country Link
US (1) US11673926B2 (pt)
EP (1) EP2718444B1 (pt)
CN (1) CN103906840B (pt)
BR (1) BR112013031564B1 (pt)
CA (1) CA2839932C (pt)
WO (1) WO2012170678A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9689016B2 (en) * 2013-12-18 2017-06-27 Caliber Biotherapeutics, Llc Method for in vivo production of deglycosylated recombinant proteins used as substrate for downstream protein glycoremodeling
CN104974994B (zh) * 2014-04-02 2019-02-26 复旦大学 一种用于n-糖蛋白去糖基化的糖苷酶及其应用
WO2015161201A1 (en) * 2014-04-18 2015-10-22 University Of Georgia Research Foundation, Inc. Carbohydrate-binding protein
EP3221455B1 (en) * 2014-11-20 2020-08-12 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. Compositions and methods for producing polypeptides with a modified glycosylation pattern in plant cells
CA3005304C (en) 2015-11-13 2024-02-20 Tarlan MAMMEDOV Production of in vivo n-deglycosylated recombinant proteins by co-expression with endo h
CN105602923B (zh) * 2016-01-18 2019-03-12 南京农业大学 一种n-糖酰胺酶d的异源表达及其应用
CA3061176A1 (en) 2017-04-24 2018-11-01 University Of Georgia Research Foundation, Inc. Sialic acid binding polypeptide
WO2020013774A1 (en) 2018-07-12 2020-01-16 Akdeniz Universitesi In vivo post-translational processing of target proteins by furin in plants: engineering, expression and production of functional active human furin in n. benthamiana plants
WO2022115083A1 (en) * 2020-11-24 2022-06-02 Akdeniz Universitesi Engineering, production and characterization of plant produced, soluble human angiotensin converting enzyme-2 as a therapeutic target in covid-19

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5238821A (en) * 1989-05-16 1993-08-24 Genzyme Corporation Endo F-free PNGase
PH30997A (en) * 1990-03-12 1997-12-23 Ciba Geigy Antipathologenically effective compositions comprising lytic peptides and hydrolytic enzymes.
US5693506A (en) 1993-11-16 1997-12-02 The Regents Of The University Of California Process for protein production in plants
EP0772619B2 (en) 1994-07-15 2010-12-08 The University of Iowa Research Foundation Immunomodulatory oligonucleotides
EP0865499B1 (en) * 1995-09-14 2009-03-18 Virginia Tech Intellectual Properties, Inc. Production of lysosomal enzymes in plant-based expression systems
US6165718A (en) 1996-01-10 2000-12-26 Novo Nordisk A/S Novo Alle Method for in vivo production of a mutant library in cells
WO2000000624A1 (en) * 1998-06-26 2000-01-06 Croptech Development Corporation Production of urokinase in plant-based expression systems
IL142041A0 (en) 1998-10-07 2002-03-10 Syngenta Participations Ag Therapeutically active proteins in plants
US20020174453A1 (en) * 2001-04-18 2002-11-21 Henry Daniell Production of antibodies in transgenic plastids
EP1485492B1 (en) * 2002-03-19 2011-12-21 Stichting Dienst Landbouwkundig Onderzoek Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta(1,4)-n-acetylglucosaminyltransferase iii) expression in plants
US20040092470A1 (en) 2002-06-18 2004-05-13 Leonard Sherry A. Dry powder oligonucleotide formualtion, preparation and its uses
CN1641037A (zh) * 2004-10-13 2005-07-20 山东大学 利用n-糖苷酶f制备蛋黄寡糖的方法
WO2007040568A2 (en) * 2004-12-01 2007-04-12 Arizona Board Of Regents, Acting For And On Behalf Of Arizona State Univeristy Production and use of human butyrylcholinesterase
CN1746302A (zh) * 2005-07-18 2006-03-15 山东大学 利用酵母生产非n-糖基化蛋白的方法
CN1793324A (zh) * 2005-11-25 2006-06-28 山东大学 利用酵母表达、生产及糖基化改造人干扰素-β的方法
HUE031698T2 (en) * 2007-06-15 2017-07-28 Medicago Inc Modification of glycoprotein production in plants
BR112013008377A2 (pt) * 2010-10-08 2020-10-06 Fraunhofer Usa Inc. molécula de ácido nucléico isolada, para produzir dois ou mais polipeptídeos alvos em uma célula de planta, método para produzir dois ou mais polipeptídeos alvos em uma célula de planta, composição, método de tratamento de um indivíduo em necessidade de pelo menos um dentre os dois ou mais polipeptídeos alvos produzidos pelo método, método de tratamento de um indivíduo em necessidade da proteína produzida pelo método e método para induzir uma resposta imunológica protetora contra um patógeno em um indivíduo

Also Published As

Publication number Publication date
EP2718444B1 (en) 2017-12-27
EP2718444A1 (en) 2014-04-16
BR112013031564B1 (pt) 2021-11-03
CA2839932A1 (en) 2012-12-13
CN103906840A (zh) 2014-07-02
US20140186886A1 (en) 2014-07-03
WO2012170678A1 (en) 2012-12-13
US11673926B2 (en) 2023-06-13
CN103906840B (zh) 2018-01-30
CA2839932C (en) 2022-07-05

Similar Documents

Publication Publication Date Title
CY2019040I1 (el) Aνti-il-23 αντισωματα
BR112013031564A2 (pt) de-glicosilação in vivo de proteínas recombinantes por co- expressão com pngase f.
CO7020871A2 (es) Anticuerpos anti-il-36r
CR20130266A (es) PROTEÍNAS DE UNIÓN AL TNF-a
CO6811812A2 (es) Anticuerpo anti-b7-h3
BR112013016235A2 (pt) anticorpo modificado com meia-vida aumentada
BR112013033342A2 (pt) variantes de fc com funções atuadoras reduzidas
DK2482106T5 (da) Multimode-fiber
BR112013029782A2 (pt) copo de bebida e conjunto de copo de bebida
DK2443154T3 (da) Bispecifikke antigenbindingsproteiner
BR112014009251A2 (pt) sensor de tampão
BR112014005242A2 (pt) composições de nanopartículas com pertídeos
BR112014011900A2 (pt) um método de purificação de anticorpo
CR20140127A (es) Anticuerpo anti-abtcr
CO6801637A2 (es) Formulaciones de anticuerpos
CO6801738A2 (es) Composición oftálmica de alta concentración de olopatadina
BR112013033614A2 (pt) fermentação de pentose por microorganismo recombinante
BR112013021221A2 (pt) cutelo com revestimento de endurecimento
BR112013029769A2 (pt) levedura recombinante
BR112014001120A2 (pt) métodos de separação de polipeptídeos
DK2462237T3 (da) Fremgangsmåder til forbedring af rekombinant proteinekspression
DK2931748T3 (da) Bmp-6-antistoffer
UA23273S (uk) Келих
CO6870027A2 (es) Composición de recipiente de vidrio
BR112014005603A2 (pt) montagem de injetor

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B25G Requested change of headquarter approved

Owner name: IBIO, INC. (US)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08G Application fees: restoration [chapter 8.7 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/06/2012, OBSERVADAS AS CONDICOES LEGAIS.